ConvaTec Group PLC (2CV)

2.4400 0.0000 (0.00%)
Closed EUR Disclaimer

ConvaTec Group PLC Company Profile

Equity Type
ConvaTec Group PLC engages in the development, manufacture, and marketing of medical products and technologies worldwide. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. It also provides ostomy care solutions, including devices, accessories, and services for people with a stoma resulting from colorectal cancer, inflammatory bowel disease, and bladder cancer. In addition, the company offers continence and critical care products and services for people with urinary continence issues related to spinal cord injuries, multiple sclerosis, spina bifida, and other causes, as well as products used in intensive care units and hospital settings. Further, it provides infusion care solutions comprising disposable infusion sets for diabetes insulin pumps, or for pumps used in continuous subcutaneous infusion treatments for conditions such as Parkinson’s disease. The company sells its products to pharmacies, hospitals, and other acute and post-acute healthcare service providers directly or through distributors and wholesalers. It serves a range of customers, including healthcare providers, patients, and manufacturers. The company was founded in 1978 and is headquartered in Reading, the United Kingdom.
Contact Information
Reading,RG1 3JH United Kingdom
44 11 8952 8100
Top Executives
Karim Bitar 56 2019 CEO & Director
John David Gibson McAdam 73 2019 Independent Chairman
Brian M. May 58 2020 Independent Non-Executive Director
Margaret Ewing 67 2017 Senior Independent Director
Sten Scheibye 71 2018 Non-Executive Director
Constantin C. Coussios 0 2020 Independent Non-Executive Director
Sharon L. O’Keefe 69 2022 Non-Executive Director
Heather L. Mason 61 2020 Independent Non-Executive Director
Kimberly S. Lody 56 2022 Independent Non-Executive Director
Jonathan P. Mason 58 2022 Group CFO & Director
Clear All
Please try another search

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.